Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

IL-23 Inhibitors Gain Physician Preference for IBD Across Europe, Yet Actual Use Continues to ...

Summary by Enid News & Eagle
Exton, PA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The treatment paradigm for inflammatory bowel disease (IBD) may be shifting faster in physician preference than in clinical practice. Across Europe, gastroenterologists are expressing strong confidence in IL-23 inhibitors and favoring earlier…

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

IL-23 Inhibitors Gain Physician Preference for IBD Across Europe, Yet Actual Use Continues to ...

Exton, PA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The treatment paradigm for inflammatory bowel disease (IBD) may be shifting faster in physician preference than in clinical practice. Across Europe, gastroenterologists are expressing strong confidence in IL-23 inhibitors and favoring earlier…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news on Thursday, August 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Exton, Pennsylvania icon

Exton, Pennsylvania

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal